Levels of Plasma Immunoglobulin G with Specificity against the Cysteine-Rich Interdomain Regions of a SemiconservedPlasmodium falciparumErythrocyte Membrane Protein 1, VAR4, Predict Protection against Malarial Anemia and Febrile Episodes
- 1 May 2006
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 74 (5) , 2867-75
- https://doi.org/10.1128/iai.74.5.2867-2875.2006
Abstract
Antibodies to variant surface antigen have been implicated as mediators of malaria immunity in studies measuring immunoglobulin G (IgG) binding to infected erythrocytes.Plasmodium falciparumerythrocyte membrane protein 1 (PfEMP1) is an important target for these antibodies, but no study has directly linked the presence of PfEMP1 antibodies in children to protection. We measured plasma IgG levels to the cysteine-rich interdomain region 1α (CIDR1α) of VAR4 (VAR4-CIDR1α), a member of a semiconserved PfEMP1 subfamily, by enzyme-linked immunosorbent assay in 561 Tanzanian individuals, who were monitored clinically for 7 months. The participants resided in Mkokola (a high-transmission village where malaria is holoendemic) or Kwamasimba (a moderate-transmission village). For comparison, plasma IgG levels to two merozoite surface protein 1 (MSP1) constructs, MSP1-19 and MSP1 block 2, and a control CIDR1 domain were measured. VAR4-CIDR1α antibodies were acquired at an earlier age in Mkokola than in Kwamasimba, but after the age of 10 years the levels were comparable in the two villages. After controlling for age and other covariates, the risk of having anemia at enrollment was reduced in VAR4-CIDR1α responders for Mkokola (adjusted odds ratio [AOR], 0.49; 95% confidence interval [CI], 0.29 to 0.88;P =0.016) and Kwamasimba (AOR, 0.33; 95% CI, 0.16 to 0.68;P= 0.003) villages. The risk of developing malaria fever was reduced among individuals with a measurable VAR4-CIDR1α response from Mkokola village (AOR, 0.51; 95% CI, 0.29 to 0.89;P= 0.018) but not in Kwamasimba. Antibody levels to the MSP1 constructs and the control CIDR1α domain were not associated with morbidity protection. These data strengthen the concept of developing vaccines based on PfEMP1.Keywords
This publication has 43 references indexed in Scilit:
- Variant surface antigens, virulence genes and the pathogenesis of malariaTrends in Parasitology, 2004
- Evidence for the Involvement of VAR2CSA in Pregnancy-associated MalariaThe Journal of Experimental Medicine, 2004
- The Fine Specificity, but Not the Invasion Inhibitory Activity, of 19-Kilodalton Merozoite Surface Protein 1-Specific Antibodies Is Associated with Resistance to Malarial Parasitemia in a Cross-Sectional Survey in The GambiaInfection and Immunity, 2004
- Plasmodium falciparum Associated with Severe Childhood Malaria Preferentially Expresses PfEMP1 Encoded by Group A var GenesThe Journal of Experimental Medicine, 2004
- The epidemiology of febrile malaria episodes in an area of unstable and seasonal transmissionTransactions of the Royal Society of Tropical Medicine and Hygiene, 2000
- Adherence of Plasmodium falciparum to Chondroitin Sulfate A in the Human PlacentaScience, 1996
- Clinical Immunity to Plasmodium falciparum Malaria Is Associated with Serum Antibodies to the 19-kDa C-Terminal Fragment of the Merozoite Surface Antigen, PfMSP-lThe Journal of Infectious Diseases, 1996
- The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of plasmodium falciparum-infected erythrocytesPublished by Elsevier ,1995
- Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferaseGene, 1988
- Gamma-Globulin and Acquired Immunity to Human MalariaNature, 1961